Aciclovir

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 2: Line 2:
Aciclovir (ACV), also known as acyclovir,<ref name="a3">Kevin ES. [https://deutschemedz.de/aciclovir "The Aciclovir"] (in German). Kevin. Retrieved 25 May 2017.</ref> is an antiviral medication.<ref name="a4">de Clercq E, Field HJ (5 October 2005). "Antiviral prodrugs – the development of successful prodrug strategies for antiviral chemotherapy". [https://en.wikipedia.org/wiki/British_Journal_of_Pharmacology British Journal of Pharmacology.] Vol. 147, no. 1. Wiley-Blackwell (published January 2006). pp. 1–11.</ref> It is primarily used for the treatment of herpes simplex virus infections, chickenpox, and shingles.<ref name="a5">[https://www.drugs.com/monograph/acyclovir.html "Acyclovir".] The American Society of Health-System Pharmacists. Archived from the original on 2015-01-05. Retrieved Jan 1, 2015.</ref> Other uses include prevention of cytomegalovirus infections following transplant and severe complications of Epstein–Barr virus infection.<ref name="a5">[https://www.drugs.com/monograph/acyclovir.html "Acyclovir".] The American Society of Health-System Pharmacists. Archived from the original on 2015-01-05. Retrieved Jan 1, 2015.</ref><ref name="a6">PMID:20739216</ref> See also [https://en.wikipedia.org/wiki/Aciclovir Aciclovir].
Aciclovir (ACV), also known as acyclovir,<ref name="a3">Kevin ES. [https://deutschemedz.de/aciclovir "The Aciclovir"] (in German). Kevin. Retrieved 25 May 2017.</ref> is an antiviral medication.<ref name="a4">de Clercq E, Field HJ (5 October 2005). "Antiviral prodrugs – the development of successful prodrug strategies for antiviral chemotherapy". [https://en.wikipedia.org/wiki/British_Journal_of_Pharmacology British Journal of Pharmacology.] Vol. 147, no. 1. Wiley-Blackwell (published January 2006). pp. 1–11.</ref> It is primarily used for the treatment of herpes simplex virus infections, chickenpox, and shingles.<ref name="a5">[https://www.drugs.com/monograph/acyclovir.html "Acyclovir".] The American Society of Health-System Pharmacists. Archived from the original on 2015-01-05. Retrieved Jan 1, 2015.</ref> Other uses include prevention of cytomegalovirus infections following transplant and severe complications of Epstein–Barr virus infection.<ref name="a5">[https://www.drugs.com/monograph/acyclovir.html "Acyclovir".] The American Society of Health-System Pharmacists. Archived from the original on 2015-01-05. Retrieved Jan 1, 2015.</ref><ref name="a6">PMID:20739216</ref> See also [https://en.wikipedia.org/wiki/Aciclovir Aciclovir].
-
Aciclovir is converted by viral [[thymidine kinase]] to aciclovir monophosphate, which is then converted by host cell kinases to aciclovir triphosphate (ACV-TP, also known as aciclo-GTP).<ref name="a28">[https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2009-PI-00595-3 "PRODUCT INFORMATION NAME OF THE DRUG OZVIR TABLETS"] (PDF). TGA eBusiness Services. Ranbaxy Australia Pty Ltd. 26 August 2011. Archived from the original on 20 August 2016. Retrieved 6 February 2014.</ref> ACV-TP is a very potent inhibitor of viral DNA replication. ACV-TP competitively inhibits and inactivates the viral DNA polymerase.<ref name="a41">["https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Valtrex/pdf/VALTREX-PI-PIL.PDF VALTREX (valacyclovir hydrochloride) Caplets -GSKSource".] gsksource.com. Retrieved 2019-08-02.</ref>[41] Its monophosphate form also incorporates into the viral DNA, resulting in chain termination.<ref name="a28">[https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2009-PI-00595-3 "PRODUCT INFORMATION NAME OF THE DRUG OZVIR TABLETS"] (PDF). TGA eBusiness Services. Ranbaxy Australia Pty Ltd. 26 August 2011. Archived from the original on 20 August 2016. Retrieved 6 February 2014.</ref><ref name="a42">[https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=12ea5042-8ea6-4ee9-a734-684a73edb373] "Acyclovir (acyclovir) Capsule Acyclovir (acyclovir) Tablet [Genpharm Inc.]". DailyMed. Genpharm Inc. November 2006. Archived from the original on 21 February 2014. Retrieved 5 February 2014.</ref><ref name="a43">[https://web.archive.org/web/20140222201708/http://www.medicines.org.uk/EMC/medicine/23721/SPC/Aciclovir+Tablets+BP+400mg "Aciclovir Tablets BP 400mg - Summary of Product Characteristics (SPC)". electronic Medicines Compendium. Actavis UK Ltd. 20 August 2012. Archived from the original on 22 February 2014. Retrieved 5 February 2014.]</ref>
+
Aciclovir is converted by viral [[thymidine kinase]] to aciclovir monophosphate, which is then converted by host cell kinases to aciclovir triphosphate (ACV-TP, also known as aciclo-GTP).<ref name="a28">[https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2009-PI-00595-3 "PRODUCT INFORMATION NAME OF THE DRUG OZVIR TABLETS"] (PDF). TGA eBusiness Services. Ranbaxy Australia Pty Ltd. 26 August 2011. Archived from the original on 20 August 2016. Retrieved 6 February 2014.</ref> ACV-TP is a very potent inhibitor of viral DNA replication (see [[DNA Replication, Transcription and Translation]]. ACV-TP competitively inhibits and inactivates the viral DNA polymerase.<ref name="a41">["https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Valtrex/pdf/VALTREX-PI-PIL.PDF VALTREX (valacyclovir hydrochloride) Caplets -GSKSource".] gsksource.com. Retrieved 2019-08-02.</ref>[41] Its monophosphate form also incorporates into the viral DNA, resulting in chain termination.<ref name="a28">[https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2009-PI-00595-3 "PRODUCT INFORMATION NAME OF THE DRUG OZVIR TABLETS"] (PDF). TGA eBusiness Services. Ranbaxy Australia Pty Ltd. 26 August 2011. Archived from the original on 20 August 2016. Retrieved 6 February 2014.</ref><ref name="a42">[https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=12ea5042-8ea6-4ee9-a734-684a73edb373] "Acyclovir (acyclovir) Capsule Acyclovir (acyclovir) Tablet [Genpharm Inc.]". DailyMed. Genpharm Inc. November 2006. Archived from the original on 21 February 2014. Retrieved 5 February 2014.</ref><ref name="a43">[https://web.archive.org/web/20140222201708/http://www.medicines.org.uk/EMC/medicine/23721/SPC/Aciclovir+Tablets+BP+400mg "Aciclovir Tablets BP 400mg - Summary of Product Characteristics (SPC)". electronic Medicines Compendium. Actavis UK Ltd. 20 August 2012. Archived from the original on 22 February 2014. Retrieved 5 February 2014.]</ref>
[[2ki5]].
[[2ki5]].

Revision as of 08:45, 5 December 2023

Caption for this structure

Drag the structure with the mouse to rotate

References

  1. Kevin ES. "The Aciclovir" (in German). Kevin. Retrieved 25 May 2017.
  2. de Clercq E, Field HJ (5 October 2005). "Antiviral prodrugs – the development of successful prodrug strategies for antiviral chemotherapy". British Journal of Pharmacology. Vol. 147, no. 1. Wiley-Blackwell (published January 2006). pp. 1–11.
  3. 3.0 3.1 "Acyclovir". The American Society of Health-System Pharmacists. Archived from the original on 2015-01-05. Retrieved Jan 1, 2015.
  4. Rafailidis PI, Mavros MN, Kapaskelis A, Falagas ME. Antiviral treatment for severe EBV infections in apparently immunocompetent patients. J Clin Virol. 2010 Nov;49(3):151-7. PMID:20739216 doi:10.1016/j.jcv.2010.07.008
  5. 5.0 5.1 "PRODUCT INFORMATION NAME OF THE DRUG OZVIR TABLETS" (PDF). TGA eBusiness Services. Ranbaxy Australia Pty Ltd. 26 August 2011. Archived from the original on 20 August 2016. Retrieved 6 February 2014.
  6. ["https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Valtrex/pdf/VALTREX-PI-PIL.PDF VALTREX (valacyclovir hydrochloride) Caplets -GSKSource".] gsksource.com. Retrieved 2019-08-02.
  7. [1] "Acyclovir (acyclovir) Capsule Acyclovir (acyclovir) Tablet [Genpharm Inc.]". DailyMed. Genpharm Inc. November 2006. Archived from the original on 21 February 2014. Retrieved 5 February 2014.
  8. "Aciclovir Tablets BP 400mg - Summary of Product Characteristics (SPC)". electronic Medicines Compendium. Actavis UK Ltd. 20 August 2012. Archived from the original on 22 February 2014. Retrieved 5 February 2014.

Proteopedia Page Contributors and Editors (what is this?)

Alexander Berchansky, Michal Harel

Personal tools